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Conclusions: Obese patients realized less clinical benefit from both operative and nonoperative treatment of lumbar disc herniation. Surgery provided similar benefit over nonoperative treatment in obese and nonobese patients.
Level of Evidence: Prognostic Level II. See Instructions for Authors for a complete description of levels of evidence.
O besity, commonly defined as a body mass index (BMI) of ‡30 kg/m 2 , affects one-third of the adult U.S. population, accounts for 10% of all U.S. health-care expenditures, and is associated with numerous clinical sequelae [1] [2] [3] [4] . The impact of obesity on musculoskeletal and spinal disease, including low back pain, facet arthritis, and degenerative disc disease, has been well documented [5] [6] [7] [8] [9] [10] [11] . Although some studies have reported increased postoperative complications after spine surgery, multiple studies have demonstrated a beneficial effect from surgery on obese patients with the appropriate indications [12] [13] [14] [15] . Despite the recognized importance of the effect of obesity on musculoskeletal conditions, the link between obesity and lumbar disc herniation has received little attention. It is difficult to draw conclusions from prior studies on this topic, as the data are somewhat contradictory 14, [16] [17] [18] [19] [20] [21] . Because of the lack of clarity on the role that obesity plays in patients with lumbar disc herniation, we sought to use the Spine Patient Outcomes Research Trial (SPORT) database to further explore this issue 22 . The purpose of this study was to determine if obesity affects outcomes following the treatment, both operative and nonoperative, of lumbar disc herniation. The hypothesis of the current study was that obese patients would have less clinical improvement over baseline function than nonobese patients after treatment for symptomatic lumbar disc herniation.
Materials and Methods
Study Design E nrollment in SPORT was conducted at thirteen multidisciplinary spine practices in eleven states across the United States. The study design and methods of SPORT have been previously published 22 .
Patients
The SPORT protocol was approved by the human subject committees at each participating center. Criteria for inclusion in the lumbar disc herniation cohort were age greater than eighteen years, radicular pain for at least six weeks with a positive nerve root tension sign and/or neurological deficit, and a confirmatory cross-sectional imaging study demonstrating intervertebral disc herniation at a level and side corresponding to their symptoms. Exclusion criteria included cauda equina syndrome, a progressive neurological deficit, malignancy, scoliosis of >15°, herniation cephalad to L2, prior back surgery, and other established contraindications to elective surgery.
Study Interventions
Patients were offered participation in either a randomized cohort or a concurrent observational cohort. Those in the randomized cohort received computergenerated random treatment assignments. Those in the observational cohort chose their treatment with their physician. Patients in the operative treatment group were designated to undergo lumbar discectomy. Patients in the nonoperative treatment group were managed with minimum nonsurgical treatment, which included active physical therapy, education, counseling with home exercise instruction, and nonsteroidal anti-inflammatory drugs if tolerated. Additionally, patients could receive any therapies above the minimum required protocol that were deemed appropriate by their physician. Because of the extensive crossover in the randomized cohort in which some patients who had been randomized to the nonoperative treatment group instead received operative treatment and vice versa, and because of the similar baseline characteristics and outcomes when comparing the randomized and observational cohorts when analyzed by treatment, the two groups were combined in this as-treated analysis.
Study Measures
Data used in this study were obtained from patient questionnaires completed at baseline, six weeks, three months, six months, one year, two years, three years, and four years after enrollment or surgery. The primary outcome measures included the physical function and bodily pain domains of the Short Form-36 (SF-36) 23 and the American Academy of Orthopaedic Surgeons MODEMS (Musculoskeletal Outcomes Data Evaluation and Management System) version of the Oswestry Disability Index 24 . The secondary outcome measures included patient self-reported improvement, work status, and satisfaction with current symptoms and with treatment 25 . Symptom severity was measured by means of the Low Back Pain Bothersomeness Index and the Sciatica Bothersomeness Index [26] [27] [28] . The SF-36 scales range from 1 to 100 points, with higher scores indicating less severe symptoms. The Oswestry Disability Index also ranges from 0 to 100 points, but higher scores indicate more severe symptoms. The Sciatica Bothersomeness Index ranges from 0 to 24 points, and the Low Back Pain Bothersomeness Index ranges from 0 to 6 points; in these indices, higher scores indicate more severe symptoms.
Statistical Analysis
The primary analyses compared changes in the clinical outcome measures from baseline as a function of the patient BMI at the time of enrollment in the study. BMI was calculated as the weight in kilograms divided by the height in meters squared according to National Institutes of Health (NIH) criteria 29 . For study purposes, the patients were divided into two groups on the basis of BMI: nonobese (BMI, <30 kg/m 2 ) and obese (BMI, ‡30 kg/m 2 ). The baseline characteristics of nonobese and obese patients were compared with use of a chi-square test for categorical variables and a t test for continuous variables. The primary analyses compared operative and nonoperative treatments with use of changes from baseline at each follow-up evaluation, with a mixed effects longitudinal regression model, including a random individual effect to account for the correlation between repeated measurements within individuals. A formal interaction term of the treatment and obesity was in the model for comparing the treatment effect in the subgroups. Because of the crossover, analyses were based on treatments actually received in the combined randomized and observational cohorts. In these as-treated analyses, the treatment indicator was a time-varying covariate, allowing for variable times of surgery. Times were measured from the beginning of treatment, which was the time of surgery for the operative treatment group and the time of enrollment for the nonoperative treatment group. Therefore, all changes from baseline prior to surgery were included in the estimates of the nonoperative treatment effect. After surgery, changes were assigned to the operative treatment group with follow-up evaluations measured from the date of surgery. Repeated measures of outcomes were used as the dependent variables, and treatment received was included as a time-varying covariate.
To adjust for potential confounding, baseline variables associated with missing data or treatment received were included as adjusting covariates in longitudinal regression models (marital status, smoking status, compensation, herniation location, working status, depression, other comorbidities, self-rated health trend, duration of the most recent episode, or treatment preference). In
addition, data for race, center, age, sex, and baseline outcome scores (for SF-36, the Oswestry Disability Index, the Sciatica Bothersomeness Index, and the Low Back Pain Bothersomeness Index) were included in the longitudinal regression models. Secondary and binary outcomes were analyzed with use of generalized estimating equations that assumed a compound symmetry working correlation structure. The outcomes were stratified by obesity, and outcomes between these subgroups at each time point were compared with use of a multiple-degrees-of-freedom Wald test. Across the four-year duration of follow-up, overall comparisons of areaunder-curve between these subgroups were made with use of a Wald test.
Computations were done with use of SAS procedures PROC MIXED for continuous data and PROC GENMOD for binary and non-normal secondary outcomes (SAS version 9.1, Windows XP Pro; SAS Institute, Cary, North Carolina). Significance was defined as p < 0.05 on the basis of a two-sided hypothesis test with no adjustments made for multiple comparisons. Such adjustments were not made because the analyses of the current study are not multiple independent comparisons from which one is looking for a single significant result, but rather consist of the longitudinal assessment over time of different dimensions of outcomes, including symptoms, function, and disability.
Source of Funding
Funds were received from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (U01-AR45444), the Office of Research on 
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I
n this study of patients with lumbar disc herniation, 854 patients had a BMI of <30 kg/m 2 and were defined as nonobese and 336 patients had a BMI of ‡30 kg/m 2 and were defined as obese. The mean BMI (and standard deviation) was 25.2 ± 2.8 kg/m 2 for the nonobese group and 35.0 ± 4.5 kg/m 2 for the obese group (p < 0.001). Differences between the groups at baseline are noted in the Appendix. Significant demographic differences were noted between the groups in sex, education, income under $50,000, and presence of a compensation claim. No significant difference was observed in the baseline work status of patients working full or part-time jobs when obese patients (59%) were compared with nonobese patients (61%) (p = 0.20). Some comorbidities differed significantly between the groups at baseline (see Appendix). The obese patient group had a higher percentage of hypertension, diabetes, depression, stomach problems, bowel problems, and other problems (see Appendix).
Compared with nonobese patients, obese patients had worse baseline scores for all three primary outcome measures: the Oswestry Disability Index (52.4 compared with 48.4 points; p = 0.003), the SF-36 bodily pain domain (25.0 compared with 27.9 points; p = 0.025), and the SF-36 physical function domain (32.5 compared with 39.7 points; p < 0.001). No significant baseline difference was observed between the groups in the SF-36 mental component summary score. A significantly higher percentage of obese patients had a preference for surgery compared with nonobese patients (55% compared with 48%; p = 0.003). Additionally, a significantly higher percentage of obese patients underwent surgery compared with nonobese patients (73% compared with 63%; p = 0.002) (see Appendix).
Operative details for those patients managed operatively are presented in Table I . When compared with nonobese patients, obese patients had a significantly greater operative time (mean, 86.5 compared with 72.3 minutes; p < 0.001), intraoperative blood loss (mean, 83.2 mL compared with 56.1 mL; p < 0.001), and length of stay (mean, 1.2 compared with 0.89 day; p < 0.001). No significant differences were observed between the groups with regard to the incidence of nerve root injury, wound hematoma, wound infection, perioperative mortality, recurrence, or additional surgery rate.
The changes in primary outcome measures of the operatively managed patients are shown in Figure 1 and Table II . With regard to the change from baseline function to the fouryear follow-up evaluation in the operative treatment group, when compared with nonobese patients, obese patients had significantly less improvement in scores for the SF-36 physical function (37.3 compared with 47.7 points; p < 0.001), the SF-36 bodily pain (44.2 compared with 50.0 points; p = 0.005), and the Oswestry Disability Index (233.7 compared with 240.1 points; p < 0.001). No significant difference between groups was observed in the change from baseline in the SF-36 mental component summary score to the four-year follow-up evaluation. At the four-year follow-up evaluation, in the operative treatment group, when compared with nonobese patients, obese patients had significantly less improvement in the Sciatica Bothersomeness Index (210.1 compared with 212.1 points; p < 0.001) and the Low Back Pain Bothersomeness Index (21.9 Change in primary outcome measures from baseline following surgical and nonoperative treatment of lumbar intervertebral disc herniation (IDH) in both obese and nonobese patients.
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compared with 22.3 points; p = 0.011). However, at baseline, no significant difference was observed in patient satisfaction or selfrated improvement when obese patients were compared with nonobese patients in the operative treatment group. At the fouryear follow-up evaluation, 77.5% of obese patients and 86.9% of nonobese patients who had been managed operatively were working a full or part-time job (p = 0.014) (see Appendix).
The changes in primary outcome measures of the nonoperatively managed patients are reported in Table II . With regard to the change from baseline function to the four-year follow-up evaluation, when compared with nonoperatively managed nonobese patients, nonoperatively managed obese patients also had significantly less improvement in the SF-36 physical function (23.1 compared with 32.0 points; p = 0.034) cancer, fibromyalgia, chronic fatigue syndrome, posttraumatic stress disorder, alcohol or drug dependency, hypertension, migraine, anxiety, and diseases of the heart, lungs, liver, kidneys, blood vessels, nervous system, stomach, or bowels), self-rated health trend, duration of the most recent episode, treatment preference, and baseline score (for SF-36, the Oswestry Disability Index, the Sciatica Bothersomeness Index, and the Low Back Pain Bothersomeness Index). ‡The SF-36 scores range from 0 to 100 points, with higher scores indicating less severe symptoms. §The Oswestry Disability Index ranges from 0 to 100 points, with lower scores indicating less severe symptoms.
and the Oswestry Disability Index (221.4 compared with 226.1 points; p < 0.001) scores, but no significant difference in the SF-36 bodily pain score (30.9 compared with 33.4 points; p = 0.39). No significant difference was observed between groups in the change from baseline in the SF-36 mental status component score at the four-year follow-up evaluation. No significant differences were observed in the secondary outcome measures, including work status, between obese and nonobese patients who had been managed nonoperatively (see Appendix). At all follow-up time points and for all primary and secondary outcome measures, there was a significant treatment effect, in favor of surgery, in both the obese and nonobese groups (Table III) (see Appendix) . The only exception to this was the measure of work status (see Appendix), for which the treatment effect was not significant in obese patients, suggesting that surgery offers no benefit over nonoperative treatment with regard to return to full or part-time work among obese patients. No significant difference in treatment effect was observed for any of the primary or secondary outcome measures when comparing obese and nonobese patients at the four-year follow-up evaluation (Table III) (see Appendix) . This result suggests that surgery offers a similar benefit over nonsurgical treatment regardless of the patient BMI.
Discussion
T
he results of the current study demonstrated that obese patients are more likely to undergo surgical intervention for lumbar disc herniation than nonobese patients and that obesity leads to increased operative time, blood loss, and length of hospital stay. The link between obesity and increased surgical intervention for lumbar disc herniation has been previously reported 5, 30 . In two separate cross-sectional studies assessing >3700 patients, Böstman demonstrated a significant association between increased BMI and operative treatment of lumbar disc herniation 5, 30 . Although the explanation of this finding remains largely unknown, the finding from the current study that obese *The values are given as the mean, with the 95% confidence interval in parentheses. The values are adjusted for race, center, age, sex, marital status, smoking status, compensation, herniation location, working status, depression, other comorbidities (including stroke, diabetes, osteoporosis, cancer, fibromyalgia, chronic fatigue syndrome, posttraumatic stress disorder, alcohol or drug dependency, hypertension, migraine, anxiety, and diseases of the heart, lungs, liver, kidneys, blood vessels, nervous system, stomach, or bowels), self-rated health trend, duration of most recent episode, treatment preference, and baseline score (for SF-36, the Oswestry Disability Index, the Sciatica Bothersomeness Index, and the Low Back Pain Bothersomeness Index). †Treatment effect is the difference between the operative and nonoperative mean change from baseline. Analysis is done with use of a mixed model with a random subject intercept term. Treatment is a time-varying covariate in which the patient experience prior to surgery is attributed to the nonoperative arm and time is measured from enrollment and the patient postoperative outcomes are attributed to the operative arm and time is measured from time of surgery. ‡The SF-36 scores range from 0 to 100 points, with higher scores indicating less severe symptoms. §The Oswestry Disability Index ranges from 0 to 100 points, with lower scores indicating less severe symptoms.
patients have a pretreatment preference for surgery may provide the answer. The perioperative findings in this study are at odds with the medical literature. A prospective study by Andreshak et al. comparing perioperative findings between obese and nonobese patients undergoing lumbar spine surgery demonstrated no difference in operative time, blood loss, or length of hospital stay 12 . The explanation for this difference in findings may be that the present study only included patients with a diagnosis of lumbar disc herniation and the study by Andreshak et al. 12 evaluated patients with a variety of diagnoses. This discrepancy warrants further investigation because of the known increased risk of infection associated with these perioperative factors 31, 32 . We believe that our results largely supported the hypothesis that obesity is associated with worse outcomes after operative or nonoperative treatment of lumbar disc herniation. At the four-year follow-up evaluation, both operatively and nonoperatively managed obese patients had significantly less improvement in the primary outcome measures of the study. The only exception was the statistically similar improvement from baseline in the SF-36 bodily pain score in obese and nonobese patients managed nonoperatively. Diseasespecific secondary outcome measures demonstrated a worse outcome for operatively managed obese patients in the Sciatica Bothersomeness Index, the Low Back Pain Bothersomeness Index, and work status. The published data on this topic are limited and serve to both support and refute the findings of the current study. In a review of nearly 1100 cases of sciatica treated nonoperatively, multivariate analysis showed that obesity was associated with adverse six-month outcomes 19 . More recently, Cole and Jackson evaluated the use of minimally invasive techniques to treat lumbar disc herniation in obese patients and concluded that this minimally invasive approach is the preferred technique to manage these patients because of favorable results and a trend toward reduced infectious complications 33 . In the current study, recurrence of disc herniation and need for additional surgical procedures did not differ significantly between obese and nonobese patients. This finding contradicts other published literature 21 . In 2010, Meredith et al. 21 retrospectively reviewed seventy-five patients who had undergone a microdiscectomy, eight (10.7%) of whom had experienced a recurrent herniation. Meredith et al. associated obesity with a twelve times higher likelihood of postoperative recurrent herniation and a thirty times higher likelihood of requiring a reoperation and concluded that weight loss counseling should be incorporated in preoperative discussions 21 .
Because of the small sample size of that previous study, the findings of our study are likely more representative of the general population.
The current study advances the literature by identifying the expected results of operative and nonoperative intervention in obese patients with the specific diagnosis of symptomatic lumbar disc herniation. To our knowledge, this study has the largest series in the literature specific to lumbar disc herniation.
This study also has the benefit of a prospective design, in which large samples of geographically diverse patients received treatment at multiple medical centers and were followed for several years. These attributes served to limit bias, increase the precision of our findings, and provide favorable generalizability of our results to clinical practice.
There were important methodological limitations to consider with this as-treated subgroup analysis of data. The initial SPORT study had been powered to compare operative treatment with nonoperative treatment for lumbar disc herniation and had not been powered for specific subgroup analyses. Even though the initial SPORT study 22 had not been powered to detect differences in clinical outcome based on BMI, the current subgroup analysis did detect such differences with significance. Confounding baseline variables in the current study, including sex, level of education, income, the presence of a compensation claim, and medical comorbidities, differed between the obese patients and the nonobese patients. These differences may have affected the results of the present study. Other limitations included a lack of reassessment of BMI at specific postoperative time points. In other studies, obese patients had gained an average of 1.5 kg by the twenty-month average follow-up period 34 . This reassessment of BMI at specific postoperative time points would have helped to identify the effect of surgery on obesity and whether pain from a spine etiology limits the ability of obese patients to lose weight. Finally, the imprecision of BMI as a marker of obesity was another important limitation. Other measures, such as skin-fold thickness or body surface area, may be more specific measures of obesity to include in future studies.
